BDI Pharma is the nation’s fastest growing, privately-held distributor of specialty pharmaceutical products. With more than two decades of expertise in the industry, the company consistently redefines niche distribution — providing commercialization solutions beyond those of the traditional wholesaler. Through an offering that includes innovative supply chain solutions, reimbursement assistance, specialized product knowledge, 24/7 emergency availability and urgent-need delivery capabilities, BDI Pharma serves as a true ally to both pharmaceutical manufacturers and healthcare providers.
The product portfolio includes IVIG, branded and generic specialty pharmaceuticals, chemotherapy, vaccines, albumin, coagulation factors, high-titer or “hyper” immune globulins and other specialty products for rare diseases. BDI Pharma is recognized as an Authorized Distributor of Record for all of the manufacturers it represents.
|
|
|
11-50 employees
View all BDI Pharma, Inc employees
|
|
Pharmaceuticals
|
|
120 Research Drive,Columbia,SC,US
|
|
1995
|
|
Distribution, Sales, Marketing, Commercialization Services, Plasma Derivatives / Recombinant Therapeutics, Specialty Pharmaceuticals
|
Edward Stiefel is the CEO of BDI Pharma, Inc. To contact Edward Stiefel email at [email protected] or [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.